<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02168413</url>
  </required_header>
  <id_info>
    <org_study_id>2013-A01734-41</org_study_id>
    <nct_id>NCT02168413</nct_id>
  </id_info>
  <brief_title>Cortical Excitability Using Robotised and Neuronavigated Transcranial Magnetic Stimulation</brief_title>
  <acronym>ROBEXCI</acronym>
  <official_title>Development of New Cortical Excitability Methodologies Using Robotised and Neuronavigated Transcranial Magnetic Stimulation.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Grenoble</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Centre National de la Recherche Scientifique, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Grenoble</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study has two main goals :&#xD;
&#xD;
        -  to develop the cortcial excitbality (CE) measurement methodology using coupling between&#xD;
           transcranial magnetic stimulation (TMS) and physiological recordings such as&#xD;
           electroencephalography (EEG) and electromyography (EMG),&#xD;
&#xD;
        -  to automatize these measurements using robotized TMS.&#xD;
&#xD;
      Assessing CE is a preliminary and crucial step in any TMS protocol, in either fundamental or&#xD;
      clinical research. It is an important indicator which determine the stimulation power applied&#xD;
      on the cortical target during the TMS experiment, or during the rTMS cure (patients). CE is&#xD;
      in general measured on the motor cortex using EMG activity as the main indicator of the&#xD;
      system's response, whatever the real cortical target is located. The present study thus&#xD;
      propose to generalize this measurement on other cortical areas in link with the actual&#xD;
      targets, and using other external recordings such as EEG. Moreover, as neuronavigation&#xD;
      systems significantly improved TMS precision in the past years, CE measurements could&#xD;
      significantly gain to become fully automatized using robotized TMS.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Eligibility Criteria :&#xD;
&#xD;
      CRITERIA OF INCLUSION&#xD;
&#xD;
        -  Major Topic (18 to 75)&#xD;
&#xD;
        -  Signed informed consent,&#xD;
&#xD;
        -  A medical examination must be done before participation in research,&#xD;
&#xD;
        -  Membership or beneficiary of a social security scheme,&#xD;
&#xD;
      CRITERIA OF NON-INCLUSION&#xD;
&#xD;
        -  Topic of under 18 and over 75 years.&#xD;
&#xD;
        -  Against-indications (CI) to the practice of MRI pacemaker or implantable defibrillator&#xD;
           or pacemaker neurosensory (risk of temporary or permanent damage to the device or&#xD;
           heating metal parts). Cochlear implants (risk of demagnetization, electrode temperature&#xD;
           rise and artifacts). Ocular or cerebral ferromagnetic foreign body close to the nerve&#xD;
           structures (risk of displacement and complications such as eye or brain damage). Metal&#xD;
           prostheses (possibility of significant artifacts according to their size and their&#xD;
           ferromagnetic character, some neurosurgical clips or heart valves can cause problems and&#xD;
           require an investigation into the exact model implanted). Topics claustrophobic.&#xD;
           Pregnant woman. Neurosurgical ventriculoperitoneal bypass valves. Irremovable metal&#xD;
           braces.&#xD;
&#xD;
        -  CI practice of TMS: the history of epilepsy or seizures during hyperthermia during&#xD;
           childhood are related ICs. Ferrom√©talliques body presence in the brain, cochlear&#xD;
           implants, pacemakers, insulin pumps, during pregnancy, about jet lag or not having slept&#xD;
           the night before the session of TMS.&#xD;
&#xD;
        -  Existence of a severe condition in general terms: cardiac, respiratory, hematologic,&#xD;
           renal, hepatic, cancerous,&#xD;
&#xD;
        -  Regular Taking anxiolytics, sedatives, antidepressants, neuroleptics,&#xD;
&#xD;
        -  Psychiatric disorder characterized,&#xD;
&#xD;
        -  Alcohol ingestion before the examination,&#xD;
&#xD;
        -  Persons referred to in Articles L1121-5 to L1121-8 CSP.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">May 14, 2014</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Electromyographic activity (EMG)</measure>
    <time_frame>One hour</time_frame>
    <description>Participants' electromyographic activity will be recorded during an average of one hour.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Electroencephalographic activity (EEG)</measure>
    <time_frame>One hour</time_frame>
    <description>Participants' electroencephalographic activity will be recorded during an average of one hour.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Oculometry : saccadic eye movement</measure>
    <time_frame>One hour</time_frame>
    <description>Participants' saccadic eye movements will be recorded during an average of one hour.</description>
  </other_outcome>
  <enrollment type="Anticipated">135</enrollment>
  <condition>Cortical Excitability</condition>
  <condition>Robotized TMS</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Ealthy subjects&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  adult subjects (18 to 75 years old)&#xD;
&#xD;
          -  consent form signed&#xD;
&#xD;
          -  medical examination done prior to the experiment&#xD;
&#xD;
          -  affiliated to the French social security&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Exclusion criteria associated to MRI : pacemaker or neurosensory stimulator or&#xD;
             implantable defibrillator. Cochlear implants. Ferromagnetic external bodies. Metal&#xD;
             prosthesis. Claustrophobia. Pregnancy. Neurochirurgical bypass valves. Fixed metal&#xD;
             dentures.&#xD;
&#xD;
          -  Exclusion criteria associated to TMS : seizures antecedent. Pacemaker or neurosensory&#xD;
             stimulator or implantable defibrillator. Cochlear implants. Ferromagnetic external&#xD;
             bodies. Pregnancy. Insulin pump. Jet-lag or sleep deprivation. Severe medical&#xD;
             affliction. Regular doses of anxiolytics, sedatives, antidepressant, neuroleptic.&#xD;
             Psychiatric illness. Alcool ingestion prior to the experiment.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thierry BOUGEROL, PUPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Grenoble</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sylvain Harquel, MS</last_name>
    <phone>+33607815939</phone>
    <email>sylvain.harquel@upmf-grenoble.Fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>UMS CNRS 3552 IRMaGe</name>
      <address>
        <city>Grenoble</city>
        <state>RA</state>
        <zip>38000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sylvain Harquel, MS</last_name>
      <phone>+33607815939</phone>
      <email>sylvain.harquel@upmf-grenoble.Fr</email>
    </contact>
    <investigator>
      <last_name>Thierry Bougerol, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2018</verification_date>
  <study_first_submitted>May 23, 2014</study_first_submitted>
  <study_first_submitted_qc>June 19, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 20, 2014</study_first_posted>
  <last_update_submitted>January 4, 2019</last_update_submitted>
  <last_update_submitted_qc>January 4, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">January 7, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cortical excitability</keyword>
  <keyword>robotized TMS</keyword>
  <keyword>EEG</keyword>
  <keyword>EMG</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

